Vantive Health
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vantive Health sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Vantive Health: 15 sponsored US clinical trials, 1 recruiting.
Vantive Health sponsors 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acute Kidney Injury (AKI), with 2 trials.
Top-decile sponsor footprint
Vantive Health ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (71.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
15 total, page 1 of 1
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
NCT05399537
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
NCT06633029
Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)
NCT03812679
Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
NCT03257410
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
NCT02860130
Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children
NCT02561247
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
NCT01181544
Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate
NCT00962000
Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer
NCT00659724
Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers
NCT00636389
Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis
NCT00636077
Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
NCT00579202
Heart Failure and Peritoneal Ultrafiltration
NCT00368641
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
NCT00287235
Gambro AK200 ULTRA Hemodiafiltration Study
NCT01202708
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Where Vantive Health enrollment is open (later-stage tilt)
1 recruiting of 15 indexed (7% open); 10 completed (67%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Acute Kidney Injury (AKI) (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vantive Health: open-pipeline peers nationwide
Peers matched on 15 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Vantive Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 trials (± recruiting share)
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Baylor Breast Care Center · 7% recruiting · 15 trials
- Geron Corporation · 7% recruiting · 15 trials
- Guerbet · 7% recruiting · 15 trials
- Joanne Kurtzberg, MD · 7% recruiting · 15 trials
Related
What to do with this Vantive Health page
15 registered trials is a research-attention snapshot, not an endorsement of Vantive Health or any single study.
- 1 of Vantive Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Kidney Injury (AKI) is the condition Vantive Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Kidney Injury (AKI) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vantive Health pipeline card: 15 registered trials from official public datasets.Report a data error.